Molecular Pharmacology: 97 (2)

February 01, 2020; Volume 97,Issue 2

Special Section on New Opportunities in Targeting WNT Signaling

You have access
Molecular Pharmacology of Class F Receptor Activation
Pawel Kozielewicz, Ainoleena Turku and Gunnar Schulte

Molecular Pharmacology February 2020, 97 (2) 62-71; DOI: https://doi.org/10.1124/mol.119.117986
Open Access
Wnt Signaling and Drug Resistance in Cancer
Zheng Zhong and David M. Virshup

Molecular Pharmacology February 2020, 97 (2) 72-89; DOI: https://doi.org/10.1124/mol.119.117978
Open Access
Interventions in WNT Signaling to Induce Cardiomyocyte Proliferation: Crosstalk with Other Pathways
W. Matthijs Blankesteijn

Molecular Pharmacology February 2020, 97 (2) 90-101; DOI: https://doi.org/10.1124/mol.119.118018

You have access
Characterization and Optimization of the Novel Transient Receptor Potential Melastatin 2 Antagonist tatM2NX
I. Cruz-Torres, D.S. Backos and P.S. Herson

Molecular Pharmacology February 2020, 97 (2) 102-111; DOI: https://doi.org/10.1124/mol.119.117549
You have access
Alternative Polyadenylation of ABC Transporters of the C-Family (ABCC1, ABCC2, ABCC3) and Implications on Posttranscriptional Micro-RNA Regulation
Oliver Bruhn, Marie Lindsay, Friederike Wiebel, Meike Kaehler, Inga Nagel, Ruwen Böhm, Christian Röder and Ingolf Cascorbi

Molecular Pharmacology February 2020, 97 (2) 112-122; DOI: https://doi.org/10.1124/mol.119.116590
You have access
Anaplastic Lymphoma Kinase Regulates Internalization of the Dopamine D2 Receptor
Donghong He and Amy W. Lasek

Molecular Pharmacology February 2020, 97 (2) 123-131; DOI: https://doi.org/10.1124/mol.119.117473
You have access
The I_Ks Ion Channel Activator Mefenamic Acid Requires KCNE1 and Modulates Channel Gating in a Subunit-Dependent Manner
Yundi Wang, Jodene Eldstrom and David Fedida

Molecular Pharmacology February 2020, 97 (2) 132-144; DOI: https://doi.org/10.1124/mol.119.117952